Register for our free email digests:
Ramsey Baghdadi
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Ramsey Baghdadi
US FDA's New Neurology Leadership Likely To Face Two Big Reviews In 2020
Eric Bastings will lead Division of Neurology I, which is expected to handle Biogen’s Alzheimer’s drug aducanumab and Sarepta’s refiling of golodirsen for DMD next year.
For Biopharma, There May Be Only One Race To Watch In 2020
Senate Majority Leader McConnell is the one constant keeping drug price controls from gaining any legislative traction.
A Short Eulogy For The Rebate Rule
The rebate rule is dead, but we should pay tribute to the failed endeavor.
Drug Price Transparency Bills May Be Empty Calories
CREATES Act Approaches Finish Line But Legislation May Fail To Launch
Broad bipartisan support and billions in projected savings mean that bill may finally pass. But whether it will work as intended to improve generic access to market remains as questionable as ever.
Drug Importation Working Group Has Been Publicly Invisible As Buzz Grows On Proposal
There are rumblings a drug importation proposal is coming, but there are no signs that the HHS/FDA working group has been active in the year since it was created.